{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:20:32Z","timestamp":1781950832982,"version":"3.54.5"},"reference-count":75,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Medications used in the treatment of inflammatory bowel disease cause a wide range of dermatologic side effects, and minimal guidance exists on how to manage them. The intention of this review article is to summarize common dermatologic adverse reactions related to inflammatory bowel disease therapy and to provide evidence\u2010based guidance on management. We conducted a scoping review using PubMed and Google Scholar to identify studies reporting clinical information on dermatologic side effects of medications used in the treatment of inflammatory bowel disease. The most commonly reported dermatological adverse effects from inflammatory bowel disease therapy were cutaneous malignancy and cutaneous infections. Thiopurines, methotrexate, tumor necrosis factor (TNF) inhibitors, interleukin (IL)\u201012\/23 inhibitors, and integrin inhibitors can be continued if nonmelanoma skin cancer arises during therapy and the malignancy should be surgically excised. TNF inhibitors and IL\u201012\/23 inhibitors can be continued in the setting of stage I surgically resectable melanoma but should be discontinued in advanced melanoma. For complicated cutaneous bacterial infections, methotrexate and TNF inhibitors should be halted, and IV antibiotics should be administered. Complicated herpes zoster infection warrants discontinuation of TNF inhibitors, whereas IL\u201012\/23 and JAK inhibitors can be continued. Inflammatory bowel disease therapies are associated with several dermatological adverse effects, and management options vary by agent. Certain agents may require discontinuation in the setting of nonmelanoma skin cancer, melanoma, and cutaneous infections. Many other dermatological adverse effects from inflammatory bowel disease therapy require specialized management or referral to dermatology.<\/jats:p>","DOI":"10.1111\/jgh.15570","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T22:58:10Z","timestamp":1623970690000},"page":"3278-3285","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Management of cutaneous side effects of inflammatory bowel disease therapy: A dermatologic viewpoint"],"prefix":"10.1111","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7362-7758","authenticated-orcid":false,"given":"Justin","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Dermatology West Virginia University School of Medicine  Morgantown West Virginia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelle","family":"Lemons","sequence":"additional","affiliation":[{"name":"Department of Dermatology West Virginia University School of Medicine  Morgantown West Virginia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Lorenze","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Pediatrics West Virginia University School of Medicine  Morgantown West Virginia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarika Sejal","family":"Chowdhary","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine West Virginia University  Morgantown West Virginia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Zinn","sequence":"additional","affiliation":[{"name":"Department of Dermatology West Virginia University School of Medicine  Morgantown West Virginia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapna","family":"Gayam","sequence":"additional","affiliation":[{"name":"Section of Gastroenterology and Hepatology West Virginia University School of Medicine  Morgantown West Virginia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.07.022"},{"key":"e_1_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw168"},{"key":"e_1_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2018.27"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000001023"},{"key":"e_1_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.12.009"},{"key":"e_1_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000152"},{"key":"e_1_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.01.010"},{"key":"e_1_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.090374"},{"key":"e_1_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12079"},{"key":"e_1_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5178.142483"},{"key":"e_1_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.092163"},{"key":"e_1_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07950.x"},{"key":"e_1_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4725.2003.29086.x"},{"key":"e_1_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2010.01613.x"},{"key":"e_1_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04226.x"},{"key":"e_1_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.79.0006"},{"key":"e_1_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2020.05.002"},{"key":"e_1_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2012.11.018"},{"key":"e_1_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-12-199312150-00007"},{"key":"e_1_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1159\/000443026"},{"key":"e_1_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2011.03.014"},{"key":"e_1_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.5070\/D3231033675"},{"key":"e_1_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-223851"},{"key":"e_1_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.451"},{"key":"e_1_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.298"},{"key":"e_1_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.186"},{"key":"e_1_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000001455"},{"key":"e_1_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200409000-00034"},{"key":"e_1_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199805000-00013"},{"key":"e_1_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809798"},{"key":"e_1_2_3_32_1","first-page":"36","article-title":"The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials","volume":"25","author":"Ortiz Z","year":"1998","journal-title":"J. Rheumatol."},{"key":"e_1_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200107)44:7<1515::AID-ART273>3.0.CO;2-7"},{"key":"e_1_2_3_34_1","first-page":"379","article-title":"Methotrexate and the photodermatitis reactivation reaction: a case report and review of the literature","volume":"66","author":"Khan AJ","year":"2000","journal-title":"Cutis"},{"key":"e_1_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1981.01650050066027"},{"key":"e_1_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20186687"},{"key":"e_1_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199502000-00018"},{"key":"e_1_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70029-X"},{"key":"e_1_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0164"},{"key":"e_1_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw053"},{"key":"e_1_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.163683"},{"key":"e_1_2_3_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21978"},{"key":"e_1_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2007.02564.x"},{"key":"e_1_2_3_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15097"},{"key":"e_1_2_3_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.537"},{"key":"e_1_2_3_46_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6703a5"},{"key":"e_1_2_3_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu606"},{"key":"e_1_2_3_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1302674"},{"key":"e_1_2_3_49_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201969"},{"key":"e_1_2_3_50_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200622"},{"key":"e_1_2_3_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209285"},{"key":"e_1_2_3_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(03)01141-0"},{"key":"e_1_2_3_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv032"},{"key":"e_1_2_3_54_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.3029"},{"key":"e_1_2_3_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-015-2344-1"},{"key":"e_1_2_3_56_1","doi-asserted-by":"publisher","DOI":"10.1159\/000449083"},{"key":"e_1_2_3_57_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.12.1593"},{"key":"e_1_2_3_58_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.2.223"},{"key":"e_1_2_3_59_1","article-title":"Anti\u2010TNF antibody\u2010induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon\u2010\u03b3\u2010expressing Th1 cells and IL\u201017A\/IL\u201022\u2010expressing Th17 cells and respond to anti\u2010IL\u201012\/IL\u201023 antibody treatment","author":"Tillack C","year":"2013","journal-title":"Gut"},{"key":"e_1_2_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.11.012"},{"key":"e_1_2_3_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13759"},{"key":"e_1_2_3_62_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2016.1230173"},{"key":"e_1_2_3_63_1","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0729"},{"key":"e_1_2_3_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2016.08.122"},{"key":"e_1_2_3_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.09.032"},{"key":"e_1_2_3_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2011.01.003"},{"key":"e_1_2_3_67_1","doi-asserted-by":"publisher","DOI":"10.5070\/D3246040714"},{"key":"e_1_2_3_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000194183.92671.b6"},{"key":"e_1_2_3_69_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.0718"},{"key":"e_1_2_3_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12307"},{"key":"e_1_2_3_71_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602773"},{"key":"e_1_2_3_72_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900750"},{"key":"e_1_2_3_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.11.035"},{"key":"e_1_2_3_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15297"},{"key":"e_1_2_3_75_1","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy150"},{"key":"e_1_2_3_76_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311079"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgh.15570","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jgh.15570","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgh.15570","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T06:32:45Z","timestamp":1693204365000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jgh.15570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":75,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1111\/jgh.15570"],"URL":"https:\/\/doi.org\/10.1111\/jgh.15570","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]},"assertion":[{"value":"2020-12-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}